|
Volumn 9, Issue 2, 2010, Pages 125-128
|
Vaccines Europe 2009
|
Author keywords
Adjuvant; Cancer vaccine; Downstream processing; Influenza; Process development; Virus like particle
|
Indexed keywords
CPG;
FLAGELLIN;
FLUBLOCK;
GLA;
INTERCELL AG;
MELCANCVAC;
PANBLOCK;
QS 21;
UNCLASSIFIED DRUG;
VACCINE;
WART VIRUS VACCINE;
ADJUVANT THERAPY;
CONFERENCE PAPER;
COST;
DRUG MANUFACTURE;
DRUG QUALITY;
EUROPE;
HUMAN;
INFLUENZA;
NONHUMAN;
PRIORITY JOURNAL;
ANTIGENS, NEOPLASM;
CANCER VACCINES;
EUROPE;
HUMANS;
INFLUENZA VACCINES;
VIRION;
|
EID: 77951671015
PISSN: 14760584
EISSN: 17448395
Source Type: Journal
DOI: 10.1586/erv.09.162 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|